Atopic Dermatitis

• FDA approval · 2012-01-05
  FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Desoximetasone (Sun Pharmaceutical Industries, Inc.). The approval updates the product's lab…

• FDA approval · 2012-01-03
  FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., resulting in changes to the product lab…

• FDA approval · 2011-08-31
  FDA Approved: TACROLIMUS — Original Application (Accord Healthcare Inc.)

  FDA approved Accord Healthcare Inc.'s original ANDA for tacrolimus, enabling a generic version of the drug. The approval covers use for prev…

• FDA approval · 2011-07-26
  FDA Approved: ALCLOMETASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for aclometasone dipropionate from Sun Pharmaceutical Industries, Inc. The approval confirms the cha…

• FDA approval · 2010-08-20
  FDA Approved: PROCTOZONE-HC — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved Rising Pharma's PROCTOZONE-HC (hydrocortisone 2.5%), an original ANDA for a generic topical corticosteroid product. The approva…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-09-04
  FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved a supplemental application for hydrocortisone butyrate by Oceanside Pharmaceuticals. This indicates an approved change to the p…

• FDA approval · 2009-07-30
  FDA Approved: ALCLOMETASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's alclometasone dipropionate for topical use via an original ANDA, enabling a generic topical corticosteroid product.

• FDA approval · 2009-05-26
  FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Betamethasone Dipropionate from Sun Pharmaceutical Industries, granting approval of a generi…

• FDA approval · 2008-09-23
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved Glenmark's original ANDA for topical betamethasone dipropionate, a generic corticosteroid, for inflammatory skin conditions…

• FDA approval · 2008-03-25
  FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)

  The FDA approved a supplemental application for Cordran (flurandrenolide) from INA Pharmaceutics, Inc.

• FDA approval · 2008-03-10
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved an original application for a generic clobetasol propionate topical product by Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2007-12-27
  FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)

  FDA approved a supplemental application for cyclosporine from Apotex Corp. This action approves additional labeling or supply under the supp…

• FDA approval · 2007-11-28
  FDA Approved: HYDROCORTISONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for Hydrocortisone by Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's appr…

• FDA approval · 2007-09-14
  FDA Approved: PIMECROLIMUS — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved a supplemental application for pimecrolimus from Oceanside Pharmaceuticals, resulting in a modification to the drug's labeling.

• FDA approval · 2007-09-12
  FDA Approved: FLUTICASONE PROPIONATE — Original Application (Golden State Medical Supply, Inc.)

  FDA approved the original application for Fluticasone Propionate, submitted by Golden State Medical Supply, Inc.

• FDA approval · 2007-08-01
  FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for NEORAL (cyclosporine) submitted by Novartis Pharmaceuticals Corporation.

• FDA approval · 2007-05-21
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

  FDA approved the original application for Betamethasone Dipropionate (a generic topical corticosteroid) from E. Fougera & Co., marking appro…

• FDA approval · 2007-05-21
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a generic topical corticosteroid, Betamethasone Dipropionate, under Sun Pharmaceutical Industries' Original Application.

• FDA approval · 2007-04-24
  FDA Approved: HALOBETASOL PROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)

  FDA approved Cosette Pharmaceuticals' original application for halobetasol propionate, a potent topical corticosteroid used to treat inflamm…

• FDA approval · 2006-08-28
  FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Diprolene (betamethasone dipropionate) submitted by Organon LLC, resulting in updated labeling f…

• FDA approval · 2006-08-14
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)

  FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under th…